Conduit Pharmaceuticals Inc. (CDT) announced on Thursday that it has entered into a strategic partnership with Sarborg Ltd. The collaboration aims to advance drug development using an innovative platform that integrates artificial intelligence and cybernetics.
With this alliance, the San Diego-based firm anticipates improvements in efficiency, cost reduction, and expedited project timelines by decreasing the need for human intervention, ultimately optimizing the drug development process.
Notably, during pre-market trading hours, Conduit’s stock price saw a significant increase of 23.90%, reaching $0.11 on the Nasdaq.
The material has been provided by InstaForex Company - www.instaforex.com
With this alliance, the San Diego-based firm anticipates improvements in efficiency, cost reduction, and expedited project timelines by decreasing the need for human intervention, ultimately optimizing the drug development process.
Notably, during pre-market trading hours, Conduit’s stock price saw a significant increase of 23.90%, reaching $0.11 on the Nasdaq.
The material has been provided by InstaForex Company - www.instaforex.com